The conundrum of differentiating Cushing's syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis

José Miguel Hinojosa-Amaya,Fernando Díaz González-Colmenero,Neri Alejandro Alvarez-Villalobos,Alejandro Salcido-Montenegro,Carolina Quintanilla-Sánchez,Pablo José Moreno-Peña,Dulce María Manzanares-Gallegos,Luis Fernando Gutiérrez-Dávila,Patricia Lizeth Castillo-Morales,Mariano García-Campa,José Gerardo González-González,Elena Varlamov,René Rodriguez-Gutiérrez,Maria Fleseriu
DOI: https://doi.org/10.1007/s11102-024-01408-w
2024-06-19
Pituitary
Abstract:Once hypercortisolemia is confirmed, differential diagnosis between Cushing's syndrome (CS) due to neoplastic endogenous hypercortisolism and non-neoplastic hypercortisolism (NNH, pseudo-Cushing's syndrome) is crucial. Due to worldwide corticotropin-releasing hormone (CRH) unavailability, accuracy of alternative tests to dexamethasone (Dex)-CRH, is clearly needed.
endocrinology & metabolism
What problem does this paper attempt to address?